Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06455930).
- Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: Complete Statistical AnalysisIndependent statistical analysis of Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03361917).
- Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: primary endpoint results, effect estimate with confidence…
- Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): Complete Statistical AnalysisIndependent statistical analysis of Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Standard Versus Continuous Capecitabine in Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standard Versus Continuous Capecitabine in Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418028).
- Standardization of Surgery on the Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standardization of Surgery on the Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679913).
- STANDUP AHFIndependent statistical analysis of Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial: Complete Statistical AnalysisIndependent statistical analysis of Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01011335).
- STAPLE-2Independent statistical analysis of The Pivotal Study of the Aptus Endovascular AAA Repair System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00507559).
- STARIndependent statistical analysis of Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARIndependent statistical analysis of Safety Study of Abatacept to Treat Refractory Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00739960).
- STARIndependent statistical analysis of Start Treatment and Recovery for Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04505540).
- STARIndependent statistical analysis of Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STARIndependent statistical analysis of Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STARIndependent statistical analysis of Tolperisone in Acute Muscle Spasm of the Back: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03802565).
- STAR Cape+BKM120 MBC With Brain Met: Complete Statistical AnalysisIndependent statistical analysis of STAR Cape+BKM120 MBC With Brain Met: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02000882).
- STAR-DIndependent statistical analysis of Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAR-OMIndependent statistical analysis of Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAR-TIndependent statistical analysis of Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04976530).
- STAR-VTIndependent statistical analysis of Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STARDUSTIndependent statistical analysis of Liraglutide and Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04881110).
- STARR-NCIndependent statistical analysis of Supporting Tailored And Responsive PrEP in Rural North Carolina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05984030).
- STARSIndependent statistical analysis of A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARSIndependent statistical analysis of Sun Protection and Tanning Awareness in Rural Schools: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06694571).
- STARSIndependent statistical analysis of Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STARS-ADHDIndependent statistical analysis of Software Treatment for Actively Reducing Severity of ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674633).
- STARTIndependent statistical analysis of Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02097641).
- STARTIndependent statistical analysis of Online Grammatical Reasoning Training for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661190).
- STARTIndependent statistical analysis of Substance Use Treatment and Recovery Team: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05086796).
- STARTIndependent statistical analysis of Wearable Technology and Alcohol-Facilitated Intimate Partner Violence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05374798).
- STARTIndependent statistical analysis of Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05405556).
- START-CKDIndependent statistical analysis of Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- START-PTSDIndependent statistical analysis of Safety Aid Reduction Treatment for PTSD Among Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04515784).
- START2Independent statistical analysis of Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02049151).
- Starting Treatment With Agonist Replacement Therapies (START): Complete Statistical AnalysisIndependent statistical analysis of Starting Treatment With Agonist Replacement Therapies (START): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00315341).
- STATIndependent statistical analysis of STAT-STatin and Aspirin in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02901067).
- STATCOPEIndependent statistical analysis of Simvastatin Therapy for Moderate and Severe COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061671).
- StATESIndependent statistical analysis of Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Statin Therapy for Ischemic and Nonischemic Cardiomyopathy: Complete Statistical AnalysisIndependent statistical analysis of Statin Therapy for Ischemic and Nonischemic Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00701220).
- Statin Therapy in Acute Influenza: Complete Statistical AnalysisIndependent statistical analysis of Statin Therapy in Acute Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02056340).
- Statin Therapy in the Treatment of Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Statin Therapy in the Treatment of Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676897).
- Statin Therapy in Young Adult Survivors of Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Statin Therapy in Young Adult Survivors of Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733953).
- StatinsIndependent statistical analysis of Pharmacological Treatment of Rett Syndrome With Statins: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02563860).
- STATUREIndependent statistical analysis of Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STDMMADIndependent statistical analysis of Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STEADFASTIndependent statistical analysis of Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- STEADFASTIndependent statistical analysis of Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…